“科学用药 健康减重”肥胖症科普沙龙在武汉成功举办

Group 1 - The event "Scientific Medication and Healthy Weight Loss" was successfully held, focusing on obesity prevention and management through expert lectures and interactive discussions [1] - The adult overweight and obesity rate in China has surpassed 50%, with a reported overweight rate of 34.3% and an obesity rate of 16.4%, indicating a significant public health issue [2] - Obesity is a major risk factor for over 200 diseases, including diabetes and cardiovascular diseases, and is the sixth leading cause of death and disability in China [2] Group 2 - The event utilized a dual online and offline approach to create an immersive weight management classroom, combining health assessments and expert lectures to enhance public understanding of scientific weight loss methods [3] - Experts emphasized the importance of using weight loss medications under medical guidance and warned against seeking quick fixes, advocating for lifestyle changes as the foundation of weight loss [3][4] - A multi-disciplinary approach was highlighted, with experts from various fields sharing strategies for personalized weight management, including medical, nutritional, and lifestyle interventions [5] Group 3 - The GLP-1RA class of drugs, particularly the weight loss version of semaglutide, is becoming a primary treatment method for obesity, with extensive clinical trials involving over 54,000 participants [6] - The treatment requires strict adherence to medical guidelines, and patients should not self-medicate or adjust dosages without professional advice [6] - The event served as a platform for knowledge dissemination and patient-physician communication, promoting a scientific approach to weight management and healthy living [6]